R19H (p.Arg19His) variant of SOST (Sclerostin)

R19H (p.Arg19His) in SOST (Sclerostin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of Sclerosteosis 1; not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.11 / 1. The record also includes population frequency data, published literature, and structural context.

R19H (p.Arg19His) variant details